Lattice Biologics (TSXV:LBL.H) Gross Margin % : 0.00% (As of Jun. 2021)

Lattice Biologics Gross Margin % Chart

Lattice Biologics Annual Data
	Trend	Dec10	Dec11	Dec12	Dec13	Dec14	Sep16	Sep17	Sep18	Sep19	Sep20
Gross Margin %		Get a 7-Day Free Trial					21.63	20.84	46.84	43.10	41.44

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Gross Margin %	Get a 7-Day Free Trial															29.14	26.59	48.03	1.38	-

Competitive Comparison of Lattice Biologics's Gross Margin %

For the Medical Devices subindustry, Lattice Biologics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lattice Biologics's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Gross Margin % falls into.

Lattice Biologics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Lattice Biologics's Gross Margin for the fiscal year that ended in Sep. 2020 is calculated as

Lattice Biologics's Gross Margin for the quarter that ended in Jun. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Lattice Biologics  (TSXV:LBL.H) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lattice Biologics had a gross margin of N/A% for the quarter that ended in Jun. 2021 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Lattice Biologics Gross Margin % Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (TSXV:LBL.H) Business Description